Skip to main content
Benchling

Benchling

We are rebuilding biotech for the AI era. When a breakthrough is delayed, the world waits. Getting a molecule from discovery to patients, or a crop from lab to field, involves thousands of slow, manual, disconnected steps. AI has the potential to change this, compressing decades of R&D work into years. But that only happens when clean, structured scientific data and AI are built into how science gets done. Benchling is the AI platform for biotech R&D. Scientists use Benchling to design experiments, capture structured data, and run AI agents and models directly in their workflows. Over 200,000 scientists around the world trust Benchling to power their most important work, from academic labs to Sanofi, Moderna, and more than half of the world's top 50 biopharma.www.benchling.com

Search complete. 7 mentions across 4 episodes found for "Benchling".

Oct 27, 2026

MayaHOST
26:56
Orgastrator Bio was founded by Ashoka Rajendra, the CEO, and Andy Hsu, which is the CTO.
MayaHOST
27:05
Ashoka was originally a product manager at Benchling, and Benchling was specifically a software that biotechs used to record experiments and organize R&D data.
MayaHOST
27:15
So it was just essentially like... kind of like a CRM or maybe just like an organization software for pharma companies and small biotech companies.
MayaHOST
27:23
Yeah, like
Max the BotHOST
11:03
Biotech is one of the most rate-sensitive innovation sectors because the cash flows are often far in the future, but today's rate environment is not exactly screaming free money.
Max the BotHOST
11:14
So the biotech version of the AI allocation question becomes, which platforms deserve capital when clinical proof is expensive? A job listing from Benchling in today's input says the company is rebuilding biotech for the AI era.
Max the BotHOST
11:29
That is not a scientific result, but it is a useful signal.
Max the BotHOST
11:32
The biotech stack is being digitized.
Apoorv AgrawalHOST
1:43
Um, Eric has the fun job of convincing all biology to run on Claude.
Apoorv AgrawalHOST
1:48
Um, he runs biology and life sciences at Anthropic, uh, launched Claude for Life Sciences last October, um, and they've got some really good partnerships with Benchling, 10x Genomics, Novo.
Apoorv AgrawalHOST
2:00
Uh, and I was just told that the last time you were here in this course was your, uh, final EE PhD scarred memory.
Eric Kauderer-AbramsGUEST
2:08
[laughs] It was a, it was a device physics final.
Amit GuptaGUEST
19:51
It took one more real gig to really put almost, like, two startups of learnings into practice.
Amit GuptaGUEST
19:57
That was at Benchling, and that's where, like, almost everything slowed down.
Amit GuptaGUEST
20:01
It's like Neo at the end of Matrix where all of a sudden the bullets are slow.
Amit GuptaGUEST
20:03
It was very, very successful.
Amit GuptaGUEST
20:47
I'm actually now putting into practice.
Amit GuptaGUEST
20:48
It wasn't like an all of a sudden moment, but I do remember where I was.
Amit GuptaGUEST
20:51
And then over that three and a half years, it was like, oh, th- this is what I'm gonna do whenever Benchling is done for me as a journey.
Amit GuptaGUEST
20:57
I'm going to go do something with this and coach and help and be kinda like what Michael Starkenberg was to me-

We value your privacy

We use cookies to understand how you use our platform and to improve your experience. Click “Accept All” to consent, or “Decline non-essential” to opt out of non-essential cookies. Read our Privacy Policy.